Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · IEX Real-Time Price · USD

8.11

-0.89 (-9.94%)

At close: Jul 2, 2024, 4:00 PM

8.43

+0.32 (4.01%)

After-hours: Jul 2, 2024, 4:46 PM EDT

Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	866	1,010	639	958	245	-
Market Cap Growth	143.21%	57.94%	-33.25%	291.63%	-	-
Enterprise Value	561	711	314	473	62	-34
PE Ratio	-	-9.92	-5.91	-16.45	-4.71	-
PS Ratio	23.26	27.64	25.72	25.86	31.94	-
PB Ratio	3.27	3.99	2.56	2.78	6.34	-
P/FCF Ratio	-6.94	-8.45	-5.47	-15.61	3.55	-
P/OCF Ratio	-7.01	-8.56	-5.86	-16.09	3.49	-
EV/Sales Ratio	15.06	19.46	12.62	12.78	8.11	-1.39
EV/EBITDA Ratio	-5.14	-7.44	-3.01	-8.46	-1.23	2.71
EV/EBIT Ratio	-4.86	-7.00	-2.90	-8.17	-1.20	2.42
EV/FCF Ratio	-4.44	-5.95	-2.69	-7.72	0.90	1.28
Debt / Equity Ratio	0.14	0.15	0.16	0.00	0.20	-0.18
Debt / EBITDA Ratio	-0.36	-0.41	-0.40	-0.03	-0.16	-0.68
Debt / FCF Ratio	-0.31	-0.33	-0.35	-0.02	0.11	-0.32
Quick Ratio	8.03	7.35	6.64	11.99	4.70	1.65
Current Ratio	8.23	7.54	6.76	12.10	4.73	1.61
Asset Turnover	0.09	0.09	0.06	0.10	0.06	-
Return on Equity (ROE)	-44.30%	-42.00%	-37.90%	-47.60%	1130.40%	-
Return on Assets (ROA)	-27.60%	-25.20%	-23.80%	-15.80%	-39.50%	-
Return on Capital (ROIC)	-41.67%	-39.10%	-38.22%	-16.81%	-112.30%	38.62%
Earnings Yield	-12.89%	-10.08%	-16.92%	-6.08%	-21.25%	-
FCF Yield	-14.09%	-11.84%	-18.27%	-6.41%	28.20%	-
Buyback Yield / Dilution	-22.65%	-7.69%	-41.40%	-94.50%	-255.37%	-
Total Shareholder Return	-22.65%	-7.69%	-41.40%	-94.50%	-255.37%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).